Analysis Of Income And Expense [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||||||||
| Revenue [abstract] | ||||||||||||||||
| Revenue from rendering of services | — | — |
18.764.494
EUR
|
— | — |
319
EUR
|
— | — | — | — | — |
16.247.018
EUR
|
— | — | — |
299
EUR
|
| Revenue | — | — |
22.098.155
EUR
|
— | — |
5.951.353
EUR
|
— | — | — | — | — |
23.564.905
EUR
|
— | — | — |
9.409.604
EUR
|
| Material income and expense [abstract] | ||||||||||||||||
| Finance income (cost) | — | — |
1.862.281
EUR
|
— | — |
2.023.328
EUR
|
— | — | — | — | — |
1.404.677
EUR
|
— | — | — |
1.399.545
EUR
|
| Miscellaneous other operating expense | — | — |
20
EUR
|
— | — |
20
EUR
|
— | — | — | — | — |
26
EUR
|
— | — | — |
26
EUR
|
| Revenue and other operating income | — | — |
18.771.194
EUR
|
— | — |
331
EUR
|
— | — | — | — | — |
16.329.126
EUR
|
— | — | — |
308
EUR
|
| Operating expense | — | — |
14.083.999
EUR
|
— | — |
1.100.683
EUR
|
— | — | — | — | — |
14.034.680
EUR
|
— | — | — |
1.017.366
EUR
|
| Expenses by nature [abstract] | ||||||||||||||||
| Raw materials and consumables used | — | — |
4.438.174
EUR
|
— | — |
349
EUR
|
— | — | — | — | — |
3.669.444
EUR
|
— | — | — |
346
EUR
|
| Classes of employee benefits expense [abstract] | ||||||||||||||||
| Employee benefits expense | — | — |
457
EUR
|
— | — |
457
EUR
|
— | — | — | — | — |
466
EUR
|
— | — | — |
466
EUR
|
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||||||||||||||||
| Depreciation and amortisation expense [abstract] | ||||||||||||||||
| Depreciation and amortisation expense | — | — |
8.439.108
EUR
|
— | — |
50
EUR
|
— | — | — | — | — |
8.410.481
EUR
|
— | — | — |
47
EUR
|
| Impairment loss (reversal of impairment loss) recognised in profit or loss | — | — |
0
EUR
|
— | — | — | — | — | — | — | — |
1.040.311
EUR
|
— | — | — | — |
| Other expenses, by nature | — | — |
729
EUR
|
— | — |
225
EUR
|
— | — | — | — | — |
423
EUR
|
— | — | — |
132
EUR
|
| Expenses, by nature | — | — |
15.956.948
EUR
|
— | — |
1.381.140
EUR
|
— | — | — | — | — |
15.441.677
EUR
|
— | — | — |
1.485.499
EUR
|
| Disclosure of attribution of expenses by nature to their function [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||||||||||||||||
| Disclosure of attribution of expenses by nature to their function [line items] | ||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||||||||
| Share of profit (loss) of associates accounted for using equity method | — | — |
3.316.295
EUR
|
— | — |
3.316.295
EUR
|
— | — | — | — | — |
7.233.458
EUR
|
— | — | — |
7.233.458
EUR
|
| Share of profit (loss) of joint ventures accounted for using equity method | — | — |
3.316.295
EUR
|
— | — |
3.316.295
EUR
|
— | — | — | — | — |
7.233.458
EUR
|
— | — | — |
7.233.458
EUR
|
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||||||||
| Comprehensive income |
0
EUR
|
0
EUR
|
5.474.728
EUR
|
5.474.728
EUR
|
0
EUR
|
4.591.875
EUR
|
0
EUR
|
0
EUR
|
0
EUR
|
0
EUR
|
0
EUR
|
7.590.203
EUR
|
0
EUR
|
7.590.203
EUR
|
0
EUR
|
7.974.618
EUR
|